CDC Merges Influenza, Coronavirus Divisions Into Unified Respiratory Unit
The federal agency restructured its flu and COVID-19 units into a unified Influenza and Respiratory Viruses Division (IRVD).
The federal agency restructured its flu and COVID-19 units into a unified Influenza and Respiratory Viruses Division (IRVD).
FDA will review Enflonsia's ability to protect high-risk children under 2 years of age during their second RSV season.
The National Foundation for Infectious Diseases (NFID) launched an initiative to streamline evidence-based information regarding respiratory disease prevention.
Preclinical studies on a new universal flu vaccine derived from baker’s yeast produced particles that provide broad protection against multiple influenza strains.
Merck is seeking expand approval for its RSV drug Enflonsia to include children under age two through their second year of risk.
A national study finds significant inconsistency among doctors when interpreting lung sounds in children suspected of pediatric pneumonia.